for CL-K1's application platform
APPLICATION PLATFORM
EFILA®
Translating CL-K1 science into targeted cellular nutrition applications.
Science, translated into practical health applications.
EFILA is the application system developed from the CL-K1® research platform. It connects fungal strain development, fermentation-derived bioactive compounds and metabolic health research with practical nutritional products.
CL-K1® represents the core ingredient science. EFILA is how that science moves toward real-world use through targeted cellular nutrition applications.
Clear applications for connected metabolic needs.
EFILA products are organized around three practical directions, each developed in jelly and tablet formats for different use scenarios.
Blood Sugar Support
Focused on healthy glucose metabolism, insulin response and daily metabolic balance.
EFILA Blood Sugar Support Jelly
A convenient jelly sachet format centered on EFILA fermentation-derived active ingredients for daily blood sugar support positioning.
View details
EFILA Blood Sugar Support Jelly brings together two decades of research by our scientific team in Korea and a convenient, individually wrapped jelly format. Its core ingredient is produced using the company's patented fungal strain and proprietary cultivation technology.
Korean Research & Patented Technology
The development of the core ingredient draws on a Korean research programme spanning twenty years and supported by multiple patents. This work provides the foundation for the strain and cultivation technology used to produce EFILA®.
Through a controlled cultivation and fermentation process, the selected strain is used to produce the ingredient at the centre of this formulation. The research and patents relate to the underlying ingredient and technology.
Key Ingredients
- EFILA® (CL-K1 mycelial culture) contains β-glucans and extracellular polysaccharides (EPS).
Ingredient Research
The CL-K1 ingredient used in EFILA has been investigated in human clinical studies.
Jelly Format & Packaging
The jelly format offers an alternative to tablets and capsules. Each serving is individually wrapped in a portable sachet, making it convenient to carry at home, at work or while travelling.
Pack size: 30 sachets × 20 g.
Directions for Use
Take 1 sachet, 1–3 times daily, 15 minutes before food.
Certification
Halal certified.
Singapore Product Notification
EFILA Blood Sugar Support is listed under Singapore's HSA Voluntary Notification System.
Notification number: VNS-2026-01-00049.
Listing does not constitute HSA approval or endorsement of the product or its efficacy.
Important Information
If you take medication or have a medical condition, consult a healthcare professional before use. Do not discontinue or adjust prescribed medication on the basis of this product information.
EFILA Advance Blood Sugar Support+
A tablet format combining EFILA with complementary nutritional ingredients for a more concentrated metabolic support application.
View details
EFILA Advance Blood Sugar Support combines the EFILA® (CL-K1 mycelial culture) with corosolic acid, selenium and zinc in a tablet formulation. It offers a different formulation and intake format within the EFILA Blood Sugar Support range.
Korean Research & Patented Technology
The core EFILA® ingredient draws on two decades of research by our scientific team in Korea, supported by multiple patents. It is produced using the company's patented fungal strain and proprietary cultivation technology, through a controlled cultivation and fermentation process.
Ingredient Research
The CL-K1 ingredient used in EFILA has been investigated in human clinical studies.
Key Ingredients
- EFILA® (CL-K1 mycelial culture) contains β-glucans and extracellular polysaccharides (EPS).
- Corosolic acid.
- Selenium (dry yeast).
- Zinc gluconate.
- Cellulose.
- Silicon dioxide.
- Magnesium stearate.
- HPMC (hydroxypropyl methylcellulose).
Ingredient Roles
Corosolic Acid: Included alongside EFILA®, selenium and zinc as part of the tablet formulation.
Selenium: An essential trace mineral involved in the body's normal antioxidant defence systems. This formula contains selenium from dry yeast.
Zinc: An essential mineral involved in normal immune function and nutrient metabolism. This formula supplies zinc as zinc gluconate.
Tablet Format & Packaging
The tablet format provides a compact alternative to jelly sachets for consumers who prefer tablets. Pack size: 90 tablets.
Directions for Use
Follow the dosage and meal-time instructions on the product label.
Manufacturing
Manufactured in a GMP- and SMART HACCP-certified facility.
Singapore Product Notification
EFILA Advance Blood Sugar Support is listed under Singapore's HSA Voluntary Notification System.
Notification number: VNS-2025-07-00175.
Listing does not constitute HSA approval or endorsement of the product or its efficacy.
Important Information
Please refer to the product label for the complete ingredient list, quantities and allergen information. If you take medication or have a medical condition, consult a healthcare professional before use. Do not discontinue or adjust prescribed medication on the basis of this product information.
Liver Support
Focused on liver metabolic function, lipid metabolism and long-term liver-related wellness.
EFILA Liver Support Jelly
A jelly sachet format positioned for liver-related wellness, alcohol burden support and everyday metabolic balance.
View details
EFILA Liver Support Jelly brings the EFILA® (CL-K1 mycelial culture) into an individually wrapped jelly formulation containing fructose. It is part of the EFILA range developed from the company's Korean ingredient research and cultivation technology.
Korean Research & Patented Technology
The core EFILA® ingredient draws on two decades of research by our scientific team in Korea, supported by multiple patents. It is produced using the company's patented fungal strain and proprietary cultivation technology, through a controlled cultivation and fermentation process.
Ingredient Research
The CL-K1 ingredient used in EFILA has been investigated in human clinical studies.
Key Ingredients
- EFILA® (CL-K1 mycelial culture) contains β-glucans and extracellular polysaccharides (EPS).
- Fructose.
Jelly Format & Packaging
The jelly provides an alternative to tablets and capsules. Each sachet is individually wrapped for convenient carrying and use at home or while travelling.
Pack size: 30 jelly sachets.
Directions for Use
Follow the serving size and frequency stated on the product label.
Important Information
Please refer to the product label for the complete ingredient list, quantities and allergen information. If you take medication or have a medical condition, consult a healthcare professional before use. Do not discontinue or adjust prescribed medication on the basis of this product information.
EFILA Liver Support Tablet+
A portable tablet format for liver metabolism and daily nutritional support, designed for consistent intake routines.
View details
Please contact us for information about this tablet format.
Key Ingredients
- Please contact us for the product ingredient information.
Directions for use
Please obtain the product label and directions before use.
Important information
Check the product label for the complete ingredient list, allergens and directions. If you take medication or have a medical condition, consult a healthcare professional before use. Do not change prescribed treatment on the basis of this product information.
Longevity
Connecting cellular energy, oxidative stress response, vitality and metabolic resilience.
EFILA Longevity Cell Booster
A jelly format for vitality-oriented EFILA applications, supporting cellular nutrition and everyday energy balance.
View details
EFILA Longevity Cell Booster combines EFILA® (CL-K1 mycelial culture) with monk fruit extract, kiwi concentrate and vitamin C. The formulation brings together a fermentation-derived ingredient, a sweetening ingredient and fruit concentrate in a portable jelly format.
Korean Research & Patented Technology
The core EFILA® ingredient draws on two decades of research by our scientific team in Korea, supported by multiple patents. It is produced using the company's patented fungal strain and proprietary cultivation technology, through a controlled cultivation and fermentation process.
Ingredient Research
The CL-K1 ingredient used in EFILA has been investigated in human clinical studies.
Key Ingredients
- EFILA® (CL-K1 mycelial culture) contains β-glucans and extracellular polysaccharides (EPS).
- Monk fruit extract, used as a sweetening ingredient.
- Kiwi concentrate, contributing to the fruit flavour.
- Vitamin C.
Jelly Format & Packaging
Individually portioned jelly sachets offer an alternative to tablets and are convenient to carry as part of a daily routine.
Pack size: 30 sachets × 20 g.
Directions for Use
Follow the serving size and frequency stated on the product label.
Storage
Store in a cool, dry place.
Important Information
Please refer to the product label for the complete ingredient list, quantities and allergen information. If you take medication or have a medical condition, consult a healthcare professional before use. Do not discontinue or adjust prescribed medication on the basis of this product information.
EFILA Advance Longevity+
A tablet format pairing EFILA with botanical support for healthy aging, resilience and long-term metabolic balance.
View details
EFILA Advance Longevity combines EFILA® (CL-K1 mycelial culture) with red ginseng extract in a tablet formulation. It brings together fermentation-derived and botanical ingredients for consumers who prefer a tablet format.
Korean Research & Patented Technology
The core EFILA® ingredient draws on two decades of research by our scientific team in Korea, supported by multiple patents. It is produced using the company's patented fungal strain and proprietary cultivation technology, through a controlled cultivation and fermentation process.
Ingredient Research
The CL-K1 ingredient used in EFILA has been investigated in human clinical studies.
Key Ingredients
- EFILA® (CL-K1 mycelial culture) contains β-glucans and extracellular polysaccharides (EPS).
- Red ginseng extract.
Red Ginseng
Red ginseng extract provides the botanical component of this formula. Ginsenosides are characteristic constituents of red ginseng; the extract is combined with EFILA® to give this tablet its distinct formulation within the Longevity range.
Tablet Format & Packaging
The compact tablet format suits consumers who prefer tablets to jelly sachets and allows the product to be incorporated into a morning and evening routine.
Pack size: 90 tablets.
Directions for Use
Take 1 tablet twice daily, in the morning and at night, on an empty stomach.
Storage
Store in a cool, dry place.
Important Information
Please refer to the product label for the complete ingredient list, quantities and allergen information. If you take medication or have a medical condition, consult a healthcare professional before use. Do not discontinue or adjust prescribed medication on the basis of this product information.
From ingredient science to everyday formats.
EFILA can support product concepts across health supplements, medical nutrition, functional foods, beverages and daily nutrition formats.
Metabolic management
For people concerned about blood sugar balance, impaired fasting glucose or insulin sensitivity.
Liver-related wellness
For people concerned about liver metabolism, fatty liver risk factors and long-term metabolic burden.
Healthy aging
For people seeking broader cellular support for energy, stress balance, resilience and vitality.